Simultaneous presence of lung adenocarcinoma and malignant pleural mesothelioma: A case report

被引：1

作者：

Yamazoe, Masatoshi ^{[1
]}

Tomioka, Hiromi ^{[1
]}

Kamada, Takahiro ^{[2
]}

Kaneko, Masahiro ^{[1
]}

Katsuyama, Eiji ^{[3
]}

机构：

[1] Kobe City Med Ctr West Hosp, Dept Resp Med, Kobe, Hyogo, Japan

[2] Natl Canc Ctr, Div Canc Immunol, Res Inst EPOC, Chiba, Japan

[3] Kobe City Med Ctr West Hosp, Dept Pathol, Kobe, Hyogo, Japan

来源：

RESPIRATORY MEDICINE CASE REPORTS | 2019年 / 26卷

关键词：

Malignant pleural mesothelioma; Lung cancer; Multiple primary cancer; Simultaneous; Autopsy; CELL CARCINOMA; PHASE-III; CONCURRENT MESOTHELIOMA; PROGNOSTIC-FACTORS; DIAGNOSIS; EXPRESSION; GUIDELINES; CISPLATIN; SURVIVAL; PATIENT;

D O I：

10.1016/j.rmcr.2018.11.011

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

The co-presence of malignant pleural mesothelioma (MPM) and lung cancer is rare. We report a 70-year-old male with exposure to asbestos. Chest computed tomography revealed a right mediastinal mass combined with an enlarged ipsilateral lymph node and left pleural effusion. Transbronchial lung biopsy revealed lung adenocarcinoma. Thoracoscopic examination revealed multiple left pleural nodules, leading to the diagnosis of MPM. Despite aggressive anticancer drug therapy, he expired due to disease progression 2.5 years after diagnosis. Autopsy confirmed an epithelioid MPM in the left pleura. MPM comorbidity in patients diagnosed with lung cancer should be considered, especially in those exposed to asbestos.

引用

页码：45 / 49

页数：5

共 35 条

[11]

Haber SE., 2010, Resp Med CME, V3, P160, DOI [10.1016/j.rmedc.2009.09.006, DOI 10.1016/J.RMEDC.2009.09.006]

[12] Guidelines for Pathologic Diagnosis of Malignant Mesothelioma 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group [J].

Husain, Aliya N. ;

Colby, Thomas ;

Ordonez, Nelson ;

Krausz, Thomas ;

Attanoos, Richard ;

Beasley, Mary Beth ;

Borczuk, Alain C. ;

Butnor, Kelly ;

Cagle, Philip T. ;

Chirieac, Lucian R. ;

Churg, Andrew ;

Dacic, Sanja ;

Fraire, Armando ;

Galateau-Salle, Francoise ;

Gibbs, Allen ;

Gown, Allen ;

Hammar, Samuel ;

Litzky, Leslie ;

Marchevsky, Alberto M. ;

Nicholson, Andrew G. ;

Roggli, Victor ;

Travis, William D. ;

Wick, Mark .

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2013, 137 (05) :647-667

[13]

Imenpour H, 2013, PATHOLOGICA, V105, P353

[14] Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma [J].

Jassem, Jacek ;

Ramlau, Rodryg ;

Santoro, Armando ;

Schuette, Wolfgang ;

Chemaissani, Assad ;

Hong, Shengyan ;

Blatter, Johannes ;

Adachi, Susumu ;

Hanauske, Axel ;

Manegold, Christian .

JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (10) :1698-1704

[15]

Kishimoto Takumi, 2003, Nihon Kokyuki Gakkai Zasshi, V41, P304

[16] Collision tumour of the pleura composed of small cell carcinoma and malignant mesothelioma [J].

Lee, AHS ;

Soomro, IN .

HISTOPATHOLOGY, 2004, 45 (03) :305-306

[17] Minute localized malignant pleural mesothelioma coexisting with multiple adenocarcinomas [J].

Maeda R. ;

Isowa N. ;

Onuma H. ;

Miura H. ;

Tokuyasu H. ;

Kawasaki Y. .

General Thoracic and Cardiovascular Surgery, 2010, 58 (2) :91-94

[18] Double cancer comprising malignant pleural mesothelioma and squamous cell carcinoma of the lung treated with radiotherapy: A case report [J].

Negi, Yoshiki ;

Kuribayashi, Kozo ;

Doi, Hiroshi ;

Funaguchi, Norihiko ;

Koda, Yuichi ;

Fujimoto, Eriko ;

Mikami, Koji ;

Minami, Toshiyuki ;

Yokoi, Takashi ;

Kijima, Takashi .

MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (02) :181-186

[19] PD-L1 expression associated with worse survival outcome in malignant pleural mesothelioma [J].

Nguyen, Bella Hai ;

Montgomery, Renn ;

Fadia, Mitali ;

Wang, Jiali ;

Ali, Sayed .

ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2018, 14 (01) :69-73

[20] Clinical significance of programmed death-1 ligand-1 and programmed death-1 ligand-2 expression in human esophageal cancer [J].

Ohigashi, Y ;

Sho, M ;

Yamada, Y ;

Tsurui, Y ;

Hamada, K ;

Ikeda, N ;

Mizuno, T ;

Yoriki, R ;

Kashizuka, H ;

Yane, K ;

Tsushima, F ;

Otsuki, N ;

Yagita, H ;

Azuma, M ;

Nakajima, Y .

CLINICAL CANCER RESEARCH, 2005, 11 (08) :2947-2953

← 1 2 3 4 →